Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Mar 15, 2020; 12(3): 276-288
Published online Mar 15, 2020. doi: 10.4251/wjgo.v12.i3.276
Published online Mar 15, 2020. doi: 10.4251/wjgo.v12.i3.276
Characteristic | n | KIF21B expression | P value | |
Low | High | |||
Age (yr) | 0.877 | |||
> 55 | 115 | 42 | 73 | |
≤ 55 | 71 | 27 | 44 | |
Gender | 0.286 | |||
Male | 102 | 34 | 68 | |
Female | 84 | 35 | 49 | |
Tumor size (cm) | 0.229 | |||
> 5 | 89 | 29 | 60 | |
≤ 5 | 97 | 40 | 57 | |
Liver cirrhosis | 0.543 | |||
Yes | 103 | 36 | 67 | |
No | 83 | 33 | 50 | |
TNM stage | 0.046a | |||
I-II | 105 | 32 | 73 | |
III-IV | 81 | 37 | 44 | |
HBsAg | 0.003b | |||
Yes | 110 | 31 | 79 | |
No | 76 | 38 | 38 | |
AFP (ng/mL) | 0.061 | |||
> 400 | 112 | 40 | 72 | |
≤ 400 | 74 | 29 | 45 | |
Vascular invasion | 0.012a | |||
Yes | 117 | 35 | 82 | |
No | 69 | 34 | 35 |
- Citation: Zhao HQ, Dong BL, Zhang M, Dong XH, He Y, Chen SY, Wu B, Yang XJ. Increased KIF21B expression is a potential prognostic biomarker in hepatocellular carcinoma. World J Gastrointest Oncol 2020; 12(3): 276-288
- URL: https://www.wjgnet.com/1948-5204/full/v12/i3/276.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i3.276